Mucosa-sparing dose painting of head and neck cancer

References

• Johansen S, Norman MH, Dale E, et al. Patterns of local-regional recurrence after conformal and intensity-modulated radiotherapy for head and neck cancer. Radiat Oncol. 2017;12(1):87.
   PubMed Web of Science ®Google Scholar
• Machtay M, Natwa M, Andrel J, et al. Pretreatment FDG-PET standardized uptake value as a prognostic factor for outcome in head and neck cancer. Head Neck. 2009;31(2):195–201.
   PubMed Web of Science ®Google Scholar
• Moan JM, Amdal CD, Malinen E, et al. The prognostic role of 18F-fluorodeoxyglucose PET in head and neck cancer depends on HPV status. Radiother Oncol. 2019;140:54–61.
   PubMed Web of Science ®Google Scholar
• Gregoire V, Langendijk JA, Nuyts S. Advances in radiotherapy for head and neck Cancer. J Clin Oncol. 2015;33(29):3277–3284.
   PubMed Web of Science ®Google Scholar
• Duprez F, De Neve W, De Gersem W, et al. Adaptive dose painting by numbers for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2011;80(4):1045–1055.
   PubMed Web of Science ®Google Scholar
• Madani I, Duprez F, Boterberg T, et al. Maximum tolerated dose in a phase I trial on adaptive dose painting by numbers for head and neck cancer. Radiother Oncol. 2011;101(3):351–355.
   PubMed Web of Science ®Google Scholar
• Madani I, Duthoy W, Derie C, et al. Positron emission tomography-guided, focal-dose escalation using intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol, Biol, Phys. 2007;68(1):126–135.
   PubMed Web of Science ®Google Scholar
• Berwouts D, Olteanu LA, Duprez F, et al. Three-phase adaptive dose-painting-by-numbers for head-and-neck cancer: initial results of the phase I clinical trial. Radiother Oncol. 2013;107(3):310–316.
   PubMed Web of Science ®Google Scholar
• Rasmussen JH, Hakansson K, Vogelius IR, et al. Phase I trial of 18F-Fludeoxyglucose based radiation dose painting with concomitant cisplatin in head and neck cancer. Radiother Oncol. 2016;120(1):76–80.
   PubMed Web of Science ®Google Scholar
• Liu F, Xi XP, Wang H, et al. PET/CT-guided dose-painting versus CT-based intensity modulated radiation therapy in locoregional advanced nasopharyngeal carcinoma. Radiat Oncol. 2017;12(1):15.
   PubMed Web of Science ®Google Scholar
• Berwouts D, Madani I, Duprez F, et al. Long-term outcome of 18 F-fluorodeoxyglucose-positron emission tomography-guided dose painting for head and neck cancer: Matched case-control study. Head Neck. 2017;39(11):2264–2275.
   PubMed Web of Science ®Google Scholar
• Welz S, Monnich D, Pfannenberg C, et al. Prognostic value of dynamic hypoxia PET in head and neck cancer: Results from a planned interim analysis of a randomized phase II hypoxia-image guided dose escalation trial. Radiother Oncol. 2017;124(3):526–532.
   PubMed Web of Science ®Google Scholar
• Olteanu LAM, Duprez F, De Neve W, et al. Late mucosal ulcers in dose-escalated adaptive dose-painting treatments for head-and-neck cancer. Acta Oncol. 2018;57(2):262–268.
   PubMed Web of Science ®Google Scholar
• Lydiatt WM, Patel SG, O'Sullivan B, et al. Head and neck cancers-major changes in the american joint committee on cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67(2):122–137.
   PubMed Web of Science ®Google Scholar
• Jensen K, Friborg J, Hansen CR, et al. The danish head and neck cancer group (DAHANCA) 2020 radiotherapy guidelines. Radiother Oncol. 2020;151:149–151.
   PubMed Web of Science ®Google Scholar
• Brouwer CL, Steenbakkers RJ, Bourhis J, et al. CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG oncology and TROG consensus guidelines. Radiother Oncol. 2015;117(1):83–90.
   PubMed Web of Science ®Google Scholar
• Vanderstraeten B, Duthoy W, De Gersem W, et al. [18F]fluoro-deoxy-glucose positron emission tomography ([18F]FDG-PET) voxel intensity-based intensity-modulated radiation therapy (IMRT) for head and neck cancer. Radiother Oncol. 2006;79(3):249–258.
   PubMed Web of Science ®Google Scholar
• Skjotskift T, Evensen ME, Furre T, et al. Dose painting for re-irradiation of head and neck cancer. Acta Oncol. 2018;57(12):1693–1699.
   PubMed Web of Science ®Google Scholar
• Lee NY, Mechalakos JG, Nehmeh S, et al. Fluorine-18-labeled fluoromisonidazole positron emission and computed tomography-guided intensity-modulated radiotherapy for head and neck cancer: a feasibility study. Int J Radiat Oncol Biol Phys. 2008;70(1):2–13.
   PubMed Web of Science ®Google Scholar
• Thorwarth D, Eschmann SM, Paulsen F, et al. Hypoxia dose painting by numbers: a planning study. Int J Radiat Oncol Biol Phys. 2007;68(1):291–300.
   PubMed Web of Science ®Google Scholar
• Skorska M, Piotrowski T, Ryczkowski A. Comparison of dose distribution for head and neck cancer patients with and without dose painting escalation during radiotherapy realized with tomotherapy unit. Br J Radiol. 2017;90(1075):20170019.
   PubMed Web of Science ®Google Scholar